Skip to main content

Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.

Citation
Dai, C., et al. “Age-Dependent Human Β Cell Proliferation Induced By Glucagon-Like Peptide 1 And Calcineurin Signaling.”. The Journal Of Clinical Investigation, pp. 3835-3844.
Center Vanderbilt University
Author Chunhua Dai, Yan Hang, Alena Shostak, Greg Poffenberger, Nathaniel Hart, Nripesh Prasad, Neil Phillips, Shawn E Levy, Dale L Greiner, Leonard D Shultz, Rita Bottino, Seung K Kim, Alvin C Powers
Abstract

Inadequate pancreatic β cell function underlies type 1 and type 2 diabetes mellitus. Strategies to expand functional cells have focused on discovering and controlling mechanisms that limit the proliferation of human β cells. Here, we developed an engraftment strategy to examine age-associated human islet cell replication competence and reveal mechanisms underlying age-dependent decline of β cell proliferation in human islets. We found that exendin-4 (Ex-4), an agonist of the glucagon-like peptide 1 receptor (GLP-1R), stimulates human β cell proliferation in juvenile but not adult islets. This age-dependent responsiveness does not reflect loss of GLP-1R signaling in adult islets, since Ex-4 treatment stimulated insulin secretion by both juvenile and adult human β cells. We show that the mitogenic effect of Ex-4 requires calcineurin/nuclear factor of activated T cells (NFAT) signaling. In juvenile islets, Ex-4 induced expression of calcineurin/NFAT signaling components as well as target genes for proliferation-promoting factors, including NFATC1, FOXM1, and CCNA1. By contrast, expression of these factors in adult islet β cells was not affected by Ex-4 exposure. These studies reveal age-dependent signaling mechanisms regulating human β cell proliferation, and identify elements that could be adapted for therapeutic expansion of human β cells.

Year of Publication
2017
Journal
The Journal of clinical investigation
Volume
127
Issue
10
Number of Pages
3835-3844
Date Published
10/2017
ISSN Number
1558-8238
DOI
10.1172/JCI91761
Alternate Journal
J. Clin. Invest.
PMID
28920919
PMCID
PMC5617654
Download citation